✦ LIBER ✦

624 Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 nonsmall cell lung cancer (NSCLC)

✍ Scribed by Komaki, R.; Milas, L.; Fujii, T.; Jay, Ro; Alan, P.; Perkins, P.; El-Naggar, A.K.; Mountain, C.; Ordonez, N.G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Tumor biomarkers in lung

✍ Komaki, R.; Milas, L.; Fujii, T.; Jay, Ro; Alan, P.; El-Naggar, A.K.; Mountain, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 164 KB

115 Apoptosis and mitosis as prognostic

✍ Ritsukol Komaki; K. Fujii; Penny Ro Perkins; Y. Jae; Pamela Mason Allen; Mountai 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Efficacy and safety of tri-modality trea

✍ P. Kumar; D. Sugarbaker; J. Herndon II; M. Langer; A.D. Elias; L. Kohman; M. Jak 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Lymphovascular space invasion and tumor

✍ Chen, Ying-Yi; Huang, Tsai-Wang; Tsai, Wen-Chiuan; Lin, Li-Fan; Cheng, Jian-Bo; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 Chinese ⚖ 580 KB

P-481 Cisplatin+gemcytabine versus cispl

✍ Er, O.; Ozkan, M.; Coskun, S.; Dogu, G.; Altinbas, M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Phase III study (MONET1) of motesanib pl

✍ Kubota, K.; Ichinose, Y.; Scagliotti, G.; Spigel, D.; Kim, J. H.; Shinkai, T.; T 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 273 KB